Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.

CONCLUSION: Peridiagnostic and cascade cancer genetic testing offers an alternative strategy to achieve population-wide identification of cancer susceptibility mutations.
PMID: 31922925 [PubMed - as supplied by publisher]

Source: Clinical Genitourinary Cancer - January 9, 2020 Category: Cancer & Oncology Authors: Offit K, Tkachuk KA, Stadler ZK, Walsh MF, Diaz-Zabala H, Levin JD, Steinsnyder Z, Ravichandran V, Sharaf RN, Frey MK, Lipkin SM, Robson ME, Hamilton JG, Vijai J, Mukherjee S Tags: J Clin Oncol Source Type: research